|
Caprion Biosciences, a world leading specialty CRO laboratory, has announced the accreditation of its laboratory located in Montreal (Canada) by the College of American Pathologists (CAP). This highly recognized laboratory accreditation adds to the certification recently received from the Centers for Medicare & Medicaid Services (CMS) under Clinical Laboratory Improvement Amendments (CLIA).
The CAP accreditation is a globally recognized programme designed to maintain the highest standard of excellence in laboratory practices. During the accreditation process, inspectors examine the laboratory records and quality control procedures for the two preceding years. CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and overall management.
"Obtaining both CAP and CLIA accreditations is a significant milestone in Caprion's development and reaffirms our long-standing commitment to meeting the most scientifically rigorous requirements for our clients. These accreditations further demonstrate the integrity of our laboratory standards, enhance Caprion's ability to support the regulatory needs of our clients at all stages of clinical development and ensure the highest quality standards of accuracy, reliability and timeliness of results," said Martin LeBlanc, CEO of Caprion Biosciences Inc.
|